Revance Aesthetics

Multiple pharmaceutical vials with blue caps arranged on white surface

DAXXIFY Targets Frown Lines With Peptide-Formulated Neurotoxin

Revolutionary peptide formula erases frown lines in just two days with six-month durability.

Revance Appoints New Chief Marketing Officer, Skincare

Woman in white sleeveless top posing against modern geometric blue and white lit backdrop

Revance Announces Julianne Hough as the Celebrity Brand Partner for DAXXIFY Brand Injectable

Revance names Julianne Hough as DAXXIFY's newest brand partner to boost consumer education and patient demand.

Dermatologist applying clear gel serum to skin using a textured applicator tool during cosmetic treatment

SkinPen Surpasses 1 Million Treatments as Microneedling Demand Accelerates

Revance surpasses 1 million SkinPen treatments as microneedling demand continues to surge.

Medical professional examining facial skin with blue medical gloves

Q&A: Revance's New CEO Nadeem Moiz Charts Bold Vision After Crown Acquisition

The newly appointed CEO Nadeem Moiz uncovers his vision for the future of aesthetics, skincare and brand evolution since Crown Laboratories' aquisition of Revance.

As one unified company, Revance collectively combines its two portfolios to provide the industry with a range of aesthetic solutions, while offering an expansive array of skin health brands for healing and rejuvenation.

Revance Unites Aesthetics and Skincare Under One Brand Following Crown Laboratories Acquisition, Expanding Portfolio and Global Presence

Following Crown Laboratories’ acquisition of Revance, the company has announced it will operate under the name Revance to reflect its combined portfolios.